Prostate-Cancer Screening - What the US Preventive Services Task Force Left Out

被引：53

作者：

Brett, Allan S. ^{[1
]}

Ablin, Richard J. ^{[2
]}

机构：

[1] Univ S Carolina, Sch Med, Dept Med, Columbia, SC 29208 USA

[2] Univ Arizona, Coll Med, Arizona Canc Ctr, Dept Pathol, Tucson, AZ 85724 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2011年 / 365卷 / 21期

关键词：

D O I：

10.1056/NEJMp1112191

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1949 / 1951

页数：3

共 6 条

[1]

[Anonymous], PROST SPEC ANT BEST

[2]

[Anonymous], SCREEN PROST CANC DR

[3]

Department of Health and Human Services, 2011, ASPE ISS BRIEF OV UN

[4] Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter [J].

Thompson, IM ;

Pauler, DK ;

Goodman, PJ ;

Tangen, CM ;

Lucia, MS ;

Parnes, HL ;

Minasian, LM ;

Ford, LG ;

Lippman, SM ;

Crawford, ED ;

Crowley, JJ ;

Coltman, CA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (22) :2239-2246

[5]

Thompson IM, 2004, NEW ENGL J MED, V351, P1470

[6] American Cancer Society Guideline for the Early Detection of Prostate Cancer Update 2010 [J].

Wolf, Andrew M. D. ;

Wender, Richard C. ;

Etzioni, Ruth B. ;

Thompson, Ian M. ;

D'Amico, Anthony V. ;

Volk, Robert J. ;

Brooks, Durado D. ;

Dash, Chiranjeev ;

Guessous, Idris ;

Andrews, Kimberly ;

DeSantis, Carol ;

Smith, Robert A. .

CA-A CANCER JOURNAL FOR CLINICIANS, 2010, 60 (02) :70-98

← 1 →